0.00Open0.77Pre Close0 Volume43 Open Interest1.50Strike Price0.00Turnover406.86%IV-79.80%PremiumAug 16, 2024Expiry Date1.09Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7610Delta0.7357Gamma0.36Leverage Ratio-0.0026Theta-0.0006Rho-0.27Eff Leverage0.0003Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet